Humanistic and Economic Burden of Misdiagnosis of Bipolar I Disorder: Predictive Models, the Role of Screening, and the Importance of Getting an Accurate Diagnosis
This webinar is intended for US Formulary decision-makers only.
Differentiating depressive episodes remains a challenge in clinical practice and often results in misdiagnosis and subsequent inappropriate treatment. This can lead to higher costs and healthcare resource utilization, and negative outcomes for patients.
This session will focus on the clinical and economic impact of misdiagnosis of Bipolar I Disorder as Major Depressive Disorder and the importance of earlier recognition and appropriate management. We will also discuss predictive algorithms and how implementation of screening tools may play a role in helping to reduce delays to accurate diagnosis.
Learning Objectives:
-
Identify the clinical challenges Healthcare Providers face in differentiating depressive episodes.
-
Recognize the clinical and economic impact of misdiagnosis of Bipolar I Disorder.
-
Understand how tools and models may help reduce misdiagnosis of patients with Bipolar I Disorder.
Registration is free for AMCP Members and Non-Members.
Speaker:
Larry Culpepper, MD, MPH
Professor, Department of Family Medicine
Boston University School of Medicine
Boston, MA
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not AMCP.
Sponsored by:
AbbVie US Medical Affairs
For individuals from the media/press who are interested in attending, please email @email.
